NCT02470260

Brief Summary

Pre-diabetes, type 2 diabetes, and their related conditions, adiposity and insulin resistance, are more prevalent in minorities Northern Manhattan compared to the general population of the United States. Despite knowledge of the main biologic determinants of these conditions (high caloric intake and sedentarism) the prevalence of these conditions continue to increase. In addition, these conditions can cause mental health problems including increased depressive symptoms and cognitive impairment. Thus, the investigators decided to conduct a community based study of middle aged Hispanic men and women aged 50 to 64 years at baseline in order to:

  1. 1.Document the prevalence and incidence, of pre-diabetes, diabetes, overweight, obesity, and associated conditions (e.g. dyslipidemia, hypertension).
  2. 2.Study how social determinants of health (SDOH) affect these conditions.
  3. 3.Study the consequences of these conditions on aging and mental health outcomes, including cognitive impairment.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Jan 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Jan 2012Jun 2026

Study Start

First participant enrolled

January 1, 2012

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

June 8, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 12, 2015

Completed
11.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

May 7, 2025

Status Verified

May 1, 2025

Enrollment Period

14.5 years

First QC Date

June 8, 2015

Last Update Submit

May 5, 2025

Conditions

Keywords

DiabetesPre-diabetesCognitionDepressive symptoms

Outcome Measures

Primary Outcomes (1)

  • Cognition

    cognitive change over at least 3 follow-ups measured with the Selective Reminding Test, Color trails test, and Animal fluency tests.

    6 years

Secondary Outcomes (3)

  • Transitions in diabetes status

    6 years

  • Metabolic syndrome

    6 years

  • Depressive symptoms

    6 years

Study Arms (3)

Diabetes

Defined by clinical history or HbA1c criteria (HbA1c greater of equal to 6.5%)

Pre-diabetes

Defined by HbA1c criteria (5.7 to 6.4%)

Normal glucose tolerance

Defined by HbA1c criteria (\< 5.7%)

Eligibility Criteria

Age50 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Middle aged Hispanics from Northern Manhattan, New York City

You may qualify if:

  • Self identified Hispanic (any Hispanic subgroup)
  • Man or woman.
  • Between the ages of 50 and 64 years at baseline

You may not qualify if:

  • History of cancer other than non-melanoma skin cancer
  • The expectation of moving out for the country permanently before during the study period
  • Presence of a clinical diagnosis of dementia, which we anticipate will be unlikely in this age group.
  • Visual, hearing, or physical impairment that precludes active participation in the study and inability to complete study questionnaires.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Irving Medical Center

New York, New York, 10032, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

whole blood for DNA extraction, plasma, sera

MeSH Terms

Conditions

Diabetes MellitusGlucose IntoleranceDepressionMetabolic Syndrome

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperglycemiaBehavioral SymptomsBehaviorInsulin ResistanceHyperinsulinism

Study Officials

  • Jose A. Luchsinger, MD

    Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine and Epidemiology

Study Record Dates

First Submitted

June 8, 2015

First Posted

June 12, 2015

Study Start

January 1, 2012

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

May 7, 2025

Record last verified: 2025-05

Locations